Status:
WITHDRAWN
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Lead Sponsor:
NYU Langone Health
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
Brief Summary
The purpose of this study is to create a database of demographics and samples in idiopathic pulmonary fibrosis.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Male or Female greater or equal to age 18.
- Referral by physician with the diagnosis of IPF, or interstitial lung disease (IPF considered likely).
- Exclusion Criteria
- (a) Unwilling or unable to give written informed consent.
Exclusion
Key Trial Info
Start Date :
November 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00212511
Start Date
November 1 2004
End Date
January 1 2018
Last Update
April 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU School of Medicine
New York, New York, United States, 10016